20516 results for «»

Filter By

20516 results

My five top trials in interventional cardiology in 2019: impact on clinical practice?

02 Jan 2020 – From GulfPCR-GIM 2020

Consult this session to learn all about the latest evidence from trials relevant for interventional cardiology, selected by EAPCI President Andreas Baumbach, and discover their impact on your daily practice: COMPLETE, BIOSTEMI, EXCEL, and more!

My five top trials in interventional cardiology in 2019 and their impact on clinical practice

Complex and challenging cases II

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to discover how to safely manage difficult complications, thanks to a selection of complex clinical cases: ascending aortic dissection, balloon rupture, retrograde PCI on CTO of ostial right coronary artery, and more!

Complex and challenging cases II

GulfPCR-GIM 2019 Award and Closing Ceremony

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to see the slides presented during GulfPCR-GIM 2019 Award and Closing Ceremony, which gathered 832 active participants, and discover who the best clinical case award winner was that year.

GulfPCR-GIM 2019 Award and Closing Ceremony

Clinical benefits of co-registration IVUS, FFR and iFR pullback in daily PCI

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn how to use IVUS to guide vessel preparation and size stents and assess angioplasty results, how SyncVision IVUS co-registration can improve efficiency of angioplasty, and how iFR co-registration can guide angioplasty in patients with diffuse disease.

Clinical benefits of co-registration IVUS, FFR and iFR pullback in daily PCI

Novel approach in the management of severely calcified lesions

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session dedicated to the Diamondback 360 coronary orbital atherectomy system to learn more about how this tool optimise the outcomes for coronary lesion preparation, how orbital atherectomy may fit into your daily practice, and what is the "must have" tool box for calcified coronary lesions.

Novel approach in the management of severely calcified lesions

Junichi Nishikawa

Tokyo, Japan

Kazuma Okamoto

Akashi, Japan

PCI optimisation: OCT and physiology in a complex multivessel disease case

18 Dec 2019 – From GulfPCR-GIM 2019

The patient is a 57-year-old male with high-risk factors and previous history of revascularisation. He presents with ischemic chest pain with NSTE-ACS. The baseline angiography shows multivessel disease and calcified LAD/D1 bifurcation (1,1,0).

The key objectives of this case are:

  1. Utility of FFR in physiological assessment of a...
PCI optimisation: OCT and physiology in a complex multivessel disease case

Updates in TAVI therapies

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn more about the latest updates in TAVI therapies, and discover the unique features of Acurate neo and Lotus Edge, the clinical evidence of both Boston Scientific TAVI platforms, while learning all about the needs of cerebral protection during TAVI procedures.

Updates in TAVI therapies

All you need to know to start optimising outcomes in PCI: OCT and physiology

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session on the new developments and future directions in functional coronary assessment to discover how and why physiology assessment/OCT could optimise procedural outcomes in PCI, and learn all about their main indications, the relevant indicators to be assessed, as well as the last changes...

All you need to know to start optimising outcomes in PCI: OCT and physiology

Shaping the future of transcatheter valve interventions

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this sesson to discover the future perspectives and innovations on transcatheter valve interventions, and learn of a new therapy in high surgical risk patients with the Tendyne clinical programme, which eliminates mitral regurgitation.

Shaping the future of transcatheter valve interventions

First-in-man randomised comparison of the Angiolite durable fluoroacrylate polymer-based sirolimus-eluting stent vs a durable fluoropolymer-based everolimus-eluting stent in patients with CAD: the ANGIOLITE trial

14 Jan 2020

The durable fluoroacrylate polymer-based sirolimus-eluting stent (Angiolite SES) has shown promising preclinical and clinical results regarding inflammatory vascular reaction and neointimal healing. J. Moreu, et al. aimed to compare performance between the Angiolite SES and an everolimus-eluting stent (EES) in patients with coronary artery disease.

Authors :

J. Moreu, R. Moreno-Gómez, A. Pérez de Prado, B. García del Blanco, R. Trillo, E. Pinar, E. Molina, J. Zueco, A. Merchán, J. Francisco Díaz-Fernández, I. Amat
EuroIntervention: the ANGIOLITE trial

How best to educate and consent our patients

19 Nov 2019 – From PCR London Valves 2019

Consult this session to learn all about how to educate and consent your patients, what they truly want to know and the techniques your should use to educate them. 

How best to educate and consent our patients

PCR London Valves 2019: Programme highlights

Hands-on workshops, Learning sessions, LIVE demonstrations, keynote lectures and more are lined up for all of the Heart Valve Team in November!

TAVI in unusual clinical situations

19 Nov 2019 – From PCR London Valves 2019

Consult this session to discover various interesting cases, involving TAVI in unusual clinical situations, such as in long-term ventricular assist device supported patient, in pure aortic regurgitation and advanced liver and kidney failure, and more!

TAVI in unusual clinical situations

Long-term clinical outcomes after SAVR and TAVI

19 Nov 2019 – From PCR London Valves 2019

Consult this session to learn all about the long-term clinical outcomes after SAVR and TAVI, thanks to a variety of studies and registries: BIVOLUT-X, STS/ACC TVT, and more!

Long-term clinical outcomes after SAVR and TAVI

Prosthesis-patient mismatch following transcatheter aortic valve replacement with supra-annular and intra-annular prostheses

03 Dec 2019

The results of this study suggest that the use of self-expandable valves could help reduce the incidence of post-procedural PPM after TAVI, especially in the population with large body size...

Reviewer

Romain Didier
Souheib Feliachi

Reviewer

Souheib Feliachi
Prosthesis-patient mismatch following TAVR with supra-annular and intra-annular prostheses

Souheib Feliachi

Brest, France

Souheib Feliachi

PCR Webinars: a perfect complement to EuroPCR!

05 Nov 2025 - 05 Nov 2025

Discover several series of free 60-minute webinars on topics such as bifurcation, FFR and high-bleeding risk patients. Join live to question experts who are In The Lab or at the Round Table, or watch on replay all year long!
PCR Webinars

Femoral versus nonfemoral peripheral access for transcatheter aortic valve replacement

05 Dec 2019

Using the data from the national prospective French registry (FRANCE TAVI), this study compared the characteristics and outcomes of TAVR procedures according to whether they were performed through a femoral or a nonfemoral peripheral access.

Reviewer

Salvatore Brugaletta
Femoral vs nonfemoral peripheral access for transcatheter aortic valve replacement
Didn’t find what you were looking for?